Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04771923Completed
Randomised, double-blind trial of tranexamic acid in hemoptysis (2 arms), sponsored by Clinical Hospital Center Zagreb. Primary endpoint: Percentage of successfully controlled iatrogenic endobronchial bleeding. Started Feb 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04771923.